review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1053/J.SEMINONCOL.2014.09.014 |
P8608 | Fatcat ID | release_la5gwzsdcfcntegq6cr3vjcbmq |
P698 | PubMed publication ID | 25499632 |
P50 | author | Paul R. Stauffer | Q51540913 |
P2093 | author name string | Mark Hurwitz | |
P433 | issue | 6 | |
P304 | page(s) | 714-729 | |
P577 | publication date | 2014-10-07 | |
P1433 | published in | Seminars in Oncology | Q14330412 |
P1476 | title | Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care | |
P478 | volume | 41 |
Q41426333 | Autophagic cell death induced by reactive oxygen species is involved in hyperthermic sensitization to ionizing radiation in human hepatocellular carcinoma cells |
Q64947725 | Cell line-specific efficacy of thermoradiotherapy in human and canine cancer cells in vitro. |
Q88679084 | Characterization of Thermally Activated Metalloenediyne Cytotoxicity in Human Melanoma Cells |
Q38804738 | Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo |
Q51494045 | Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial. |
Q41592840 | Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial |
Q33902253 | Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. |
Q36787517 | Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies |
Q58570866 | First in vitro evidence of modulated electro-hyperthermia treatment performance in combination with megavoltage radiation by clonogenic assay |
Q36468034 | Hemodialysis Catheter Heat Transfer for Biofilm Prevention and Treatment |
Q90385112 | Hyperthermia in cervical cancer - current status |
Q64981077 | Hyperthermia induces therapeutic effectiveness and potentiates adjuvant therapy with non-targeted and targeted drugs in an in vitro model of human malignant melanoma. |
Q48155911 | Molecular Genetic Analysis of Human Endometrial Mesenchymal Stem Cells That Survived Sublethal Heat Shock. |
Q89471662 | Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy |
Q91872045 | Nano-Enhanced Drug Delivery and Therapeutic Ultrasound for Cancer Treatment and Beyond |
Q91827989 | Nanoparticles and nanothermia for malignant brain tumors, a suggestion of treatment for further investigations |
Q30356280 | Non-Invasive Radiofrequency Field Treatment to Produce Hepatic Hyperthermia: Efficacy and Safety in Swine |
Q26799981 | Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid |
Q36196867 | Porous Pt Nanoparticles with High Near-Infrared Photothermal Conversion Efficiencies for Photothermal Therapy |
Q55002491 | Recommendations for In Vitro and In Vivo Testing of Magnetic Nanoparticle Hyperthermia Combined with Radiation Therapy. |
Q104802093 | State of the Science: The role of HIPEC in the treatment of ovarian cancer |
Q33777635 | Temperature-dependent shape-responsive fluorescent nanospheres for image-guided drug delivery |
Q64972619 | The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial. |
Q38724564 | The future of biology in driving the field of hyperthermia |
Q64232827 | Ultrasound Hyperthermia Technology for Radiosensitization |
Search more.